Jan-16 -

Genito-Urinary Group

EORTC 30994 – Randomized phase III trial comparing immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4, and/or N+M0 transitional cell carcinoma (TCC) of the bladder.

EORTC’s study comparing two treatment regiments with a seven-year follow-up, in patients with pT3-pT4, and/or N+M0 transitional cell carcinoma (TCC) of the bladder, found that even though immediate chemotherapy did not improve overall survival, it improved progression free survival in these patients.

READ MORE